Literature DB >> 6783406

Binding of ribosomes to linear and circular forms of the 5'-terminal leader fragment of tobacco-mosaic-virus RNA.

M Konarska, W Filipowicz, H Domdey, H J Gross.   

Abstract

The sequence of the 5'-terminal leader fragment preceding the AUG codon in the RNA of tobacco mosaic virus (TMV), tomato strain, SPS isolate, has been determined. This RNA, similarly to the RNAs of the U1 and Dahlemense strains of TMV [Kukla et al. (1979) Eur. J. Biochem. 98, 61--66] has the 7-methylguanosine(5')triphospho(5')guanosine cap separated from the initiation codon by a long stretch of nucleotides devoid of guanosine residues. The RNase-T1-resistant 73-nucleotide-long leader fragment of TMV RNA from the SPS isolate was assayed for its ability to interact with eukaryotic and prokaryotic ribosomes. The linear fragment, labelled either at its 5' or 3' end, efficiently formed disome initiation complexes when incubated with wheat-germ protein-synthesis extract. In contrast to its linear counterpart, the circular covalently closed RNA leader fragment, obtained in a reaction catalysed by T4 RNA ligase, was unable to interact with wheat germ ribosomes. Both kinds of leader fragment bound equally well to Escherichia coli 70-S ribosomes. The results offer further support to the notion that in eukaryotic initiation the free 5' end (either capped or uncapped) is required for mRNA interaction with ribosomes. Furthermore, they suggest that both ribosomes found in disome initiation complexes with the TMV RNA leader fragment enter the mRNA sequentially via the free 5' terminus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783406     DOI: 10.1111/j.1432-1033.1981.tb05139.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  31 in total

1.  Both the 5' untranslated region and the sequences surrounding the start site contribute to efficient initiation of translation in vitro.

Authors:  D Falcone; D W Andrews
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

Review 2.  Satellite RNAs of plant viruses: structures and biological effects.

Authors:  M J Roossinck; D Sleat; P Palukaitis
Journal:  Microbiol Rev       Date:  1992-06

3.  Deletion analysis of the 5' untranslated leader sequence of tobacco mosaic virus RNA.

Authors:  N Takamatsu; Y Watanabe; T Iwasaki; T Shiba; T Meshi; Y Okada
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Circular mRNA can direct translation of extremely long repeating-sequence proteins in vivo.

Authors:  R Perriman; M Ares
Journal:  RNA       Date:  1998-09       Impact factor: 4.942

5.  Cyclization of RNA 3'-terminal phosphate by cyclase from HeLa cells proceeds via formation of N(3')pp(5')A activated intermediate.

Authors:  W Filipowicz; K Strugala; M Konarska; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

Review 6.  Roles of Long Noncoding RNAs and Circular RNAs in Translation.

Authors:  Marina Chekulaeva; Nikolaus Rajewsky
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-06-03       Impact factor: 10.005

7.  Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes.

Authors:  M Kozak
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  The 5'-leader sequence of tobacco mosaic virus RNA enhances the expression of foreign gene transcripts in vitro and in vivo.

Authors:  D R Gallie; D E Sleat; J W Watts; P C Turner; T M Wilson
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

9.  Non-canonical translation mechanisms in plants: efficient in vitro and in planta initiation at AUU codons of the tobacco mosaic virus enhancer sequence.

Authors:  J Schmitz; D Prüfer; W Rohde; E Tacke
Journal:  Nucleic Acids Res       Date:  1996-01-15       Impact factor: 16.971

10.  RNA 3'-terminal phosphate cyclase activity and RNA ligation in HeLa cell extract.

Authors:  W Filipowicz; M Konarska; H J Gross; A J Shatkin
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.